Literature DB >> 33477018

Homologous recombination deficiency: how genomic signatures are generated.

Jeremy Setton1, Jorge S Reis-Filho2, Simon N Powell3.   

Abstract

Cancer genomes harbor mutational and structural rearrangements that are jointly shaped by DNA damage and repair mechanisms. Accumulating evidence suggests that genetic alterations in DNA repair-defective tumors reflect the scars caused by the use of backup DNA repair mechanisms needed to maintain cellular viability. Detailed analysis of the patterns of mutations and structural rearrangements present in BRCA1/2-deficient tumors has allowed for the delineation of genomic signatures that reflect alternative repair with inactive homologous recombination (HR). Here we aim to summarize recent advances in the analysis of genomic signatures associated with HR-deficiency and examine recent studies that have shed light on the backup repair mechanisms responsible for genomic scarring in HR-deficient tumors.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33477018      PMCID: PMC8377996          DOI: 10.1016/j.gde.2021.01.002

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  62 in total

Review 1.  Replication-Coupled DNA Repair.

Authors:  David Cortez
Journal:  Mol Cell       Date:  2019-06-06       Impact factor: 17.970

Review 2.  Templated Insertions: A Smoking Gun for Polymerase Theta-Mediated End Joining.

Authors:  Joost Schimmel; Robin van Schendel; Johan T den Dunnen; Marcel Tijsterman
Journal:  Trends Genet       Date:  2019-07-08       Impact factor: 11.639

3.  53BP1 fosters fidelity of homology-directed DNA repair.

Authors:  Fena Ochs; Kumar Somyajit; Matthias Altmeyer; Maj-Britt Rask; Jiri Lukas; Claudia Lukas
Journal:  Nat Struct Mol Biol       Date:  2016-06-27       Impact factor: 15.369

Review 4.  The Tumor Suppressor PALB2: Inside Out.

Authors:  Mandy Ducy; Laura Sesma-Sanz; Laure Guitton-Sert; Anahita Lashgari; Yuandi Gao; Nadine Brahiti; Amélie Rodrigue; Guillaume Margaillan; Marie-Christine Caron; Jacques Côté; Jacques Simard; Jean-Yves Masson
Journal:  Trends Biochem Sci       Date:  2019-01-10       Impact factor: 13.807

5.  Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.

Authors:  Wassim Abida; David Campbell; Akash Patnaik; Jeremy D Shapiro; Brieuc Sautois; Nicholas J Vogelzang; Eric G Voog; Alan H Bryce; Ray McDermott; Francesco Ricci; Julie Rowe; Jingsong Zhang; Josep Maria Piulats; Karim Fizazi; Axel S Merseburger; Celestia S Higano; Laurence E Krieger; Charles J Ryan; Felix Y Feng; Andrew D Simmons; Andrea Loehr; Darrin Despain; Melanie Dowson; Foad Green; Simon P Watkins; Tony Golsorkhi; Simon Chowdhury
Journal:  Clin Cancer Res       Date:  2020-02-21       Impact factor: 12.531

6.  Mechanism of tandem duplication formation in BRCA1-mutant cells.

Authors:  Nicholas A Willis; Richard L Frock; Francesca Menghi; Erin E Duffey; Arvind Panday; Virginia Camacho; E Paul Hasty; Edison T Liu; Frederick W Alt; Ralph Scully
Journal:  Nature       Date:  2017-11-22       Impact factor: 49.962

7.  Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors.

Authors:  Timothy A Yap; Brent O'Carrigan; Marina S Penney; Joline S Lim; Jessica S Brown; Maria J de Miguel Luken; Nina Tunariu; Raquel Perez-Lopez; Daniel Nava Rodrigues; Ruth Riisnaes; Ines Figueiredo; Suzanne Carreira; Brian Hare; Katherine McDermott; Saira Khalique; Chris T Williamson; Rachael Natrajan; Stephen J Pettitt; Christopher J Lord; Udai Banerji; John Pollard; Juanita Lopez; Johann S de Bono
Journal:  J Clin Oncol       Date:  2020-06-22       Impact factor: 44.544

8.  Patterns of somatic structural variation in human cancer genomes.

Authors:  Yilong Li; Nicola D Roberts; Jeremiah A Wala; Ofer Shapira; Steven E Schumacher; Kiran Kumar; Ekta Khurana; Sebastian Waszak; Jan O Korbel; James E Haber; Marcin Imielinski; Joachim Weischenfeldt; Rameen Beroukhim; Peter J Campbell
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

9.  Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs.

Authors:  Kevin Hadi; Xiaotong Yao; Julie M Behr; Aditya Deshpande; Charalampos Xanthopoulakis; Huasong Tian; Sarah Kudman; Joel Rosiene; Madison Darmofal; Joseph DeRose; Rick Mortensen; Emily M Adney; Alon Shaiber; Zoran Gajic; Michael Sigouros; Kenneth Eng; Jeremiah A Wala; Kazimierz O Wrzeszczyński; Kanika Arora; Minita Shah; Anne-Katrin Emde; Vanessa Felice; Mayu O Frank; Robert B Darnell; Mahmoud Ghandi; Franklin Huang; Sally Dewhurst; John Maciejowski; Titia de Lange; Jeremy Setton; Nadeem Riaz; Jorge S Reis-Filho; Simon Powell; David A Knowles; Ed Reznik; Bud Mishra; Rameen Beroukhim; Michael C Zody; Nicolas Robine; Kenji M Oman; Carissa A Sanchez; Mary K Kuhner; Lucian P Smith; Patricia C Galipeau; Thomas G Paulson; Brian J Reid; Xiaohong Li; David Wilkes; Andrea Sboner; Juan Miguel Mosquera; Olivier Elemento; Marcin Imielinski
Journal:  Cell       Date:  2020-10-01       Impact factor: 66.850

10.  Mechanistic basis for microhomology identification and genome scarring by polymerase theta.

Authors:  Juan Carvajal-Garcia; Jang-Eun Cho; Pablo Carvajal-Garcia; Wanjuan Feng; Richard D Wood; Jeff Sekelsky; Gaorav P Gupta; Steven A Roberts; Dale A Ramsden
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-31       Impact factor: 11.205

View more
  5 in total

Review 1.  Guardians of the Genome: BRCA2 and Its Partners.

Authors:  Hang Phuong Le; Wolf-Dietrich Heyer; Jie Liu
Journal:  Genes (Basel)       Date:  2021-08-10       Impact factor: 4.141

Review 2.  Cancer testis antigens and genomic instability: More than immunology.

Authors:  Ash Jay; Diedre Reitz; Satoshi H Namekawa; Wolf-Dietrich Heyer
Journal:  DNA Repair (Amst)       Date:  2021-08-17

3.  DNA nicks induce mutational signatures associated with BRCA1 deficiency.

Authors:  Yi-Li Feng; Qian Liu; Ruo-Dan Chen; Si-Cheng Liu; Zhi-Cheng Huang; Kun-Ming Liu; Xiao-Ying Yang; An-Yong Xie
Journal:  Nat Commun       Date:  2022-07-25       Impact factor: 17.694

4.  Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma.

Authors:  Xiaohui Wu; Haijia Tang; Wen-Hao Xu; Haidan Tang; Shiyin Wei; Aihetaimujiang Anwaier; Haineng Huang; Yuan-Yuan Qu; Hailiang Zhang; Shuai Zhao; Hui Li; Wangrui Liu; Hongjing Chen; Chen Ding; Dingwei Ye
Journal:  Front Genet       Date:  2021-12-07       Impact factor: 4.599

Review 5.  Genomic Signatures in HPV-Associated Tumors.

Authors:  Suleman S Hussain; Devon Lundine; Jonathan E Leeman; Daniel S Higginson
Journal:  Viruses       Date:  2021-10-05       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.